Overview of Brain Metastases Care at Duke Cancer Institute
When cancer spreads to the brain, known as brain metastases, patients and families seek high-level, coordinated care from a specialized team. The Duke Cancer Institute Brain Metastases Center provides an integrated model that combines neurosurgery, medical oncology, radiation oncology, neuroradiology, neuropathology, and supportive care. This structure is designed to tailor treatment to tumor type, location, genetic profile, and overall health, while coordinating advanced options such as surgery, stereotactic radiosurgery, and systemic therapies. The following sections explain the conditions treated, roles of the care team, and what to expect across the care journey.
Conditions and Typical Presentations
Common Cancers That Spread to the Brain
Brain metastases most often arise from primary cancers such as lung, breast, melanoma, kidney, and colorectal cancer. The symptoms you experience depend on the size, number, and location of lesions, as well as the underlying cancer type. Recognizing early signs and connecting with a specialized center can help ensure timely evaluation and treatment planning.
Multidisciplinary Care Team Structure
At Duke Cancer Institute, brain metastases care is organized through a multidisciplinary tumor board that brings together neurosurgeons, medical oncologists, radiation oncologists, neuroradiologists, neuropathologists, neuropsychologists, and supportive care clinicians. This collaboration allows each case to be reviewed in detail to recommend a cohesive, evidence-based plan. Patients and referring providers receive clear communication, with each specialist contributing their expertise to optimize safety and effectiveness.
Key Diagnostic and Assessment Steps
Neuroimaging and Pathology
Care typically begins with high-resolution brain magnetic resonance imaging (MRI), often with contrast, to characterize the lesions. A biopsy or surgical resection may be recommended to obtain tissue for molecular profiling, which can identify targets for therapy and inform treatment selection. A comprehensive neurological exam and assessment of your overall health are also used to guide the most appropriate interventions.
| Attribute | Verified Detail | Source Type |
|---|---|---|
| Primary cancers most often causing brain metastases | Lung, breast, melanoma, kidney, colorectal | Clinical guidelines |
| Initial imaging modality | Brain MRI with contrast | Institutional protocol |
| Role of tissue testing | Guides targeted and systemic treatment selection | Pathology standard of care |
| Typical specialists on care team | Neurosurgery, medical oncology, radiation oncology, neuroradiology, neuropathology, supportive care | Multidisciplinary tumor board structure |
Treatment Approaches and Options
Surgical Management
Surgery may be recommended to remove one or a limited number of lesions, particularly when diagnosis is uncertain, the tumor is causing significant pressure, or the location is accessible. The goals include obtaining tissue for testing, relieving symptoms, and enabling more effective subsequent therapies. Candidates for surgery are evaluated based on tumor factors and overall health, with an emphasis on balancing potential benefits and risks.
Radiation Therapy Techniques
Radiation is commonly used either after surgery or as a primary treatment, depending on the number, size, and location of metastases. Stereotactic radiosurgery delivers precisely focused radiation in one or few sessions, preserving more healthy tissue while targeting tumors. For more extensive disease, whole-brain radiation therapy may be considered, often combined with systemic treatments to manage both brain and distant disease.
Systemic Therapies and Molecular Testing
Medical oncologists may recommend therapies such as immunotherapy, targeted agents, or chemotherapy, depending on the cancer type and molecular profile. Comprehensive genomic profiling of the tumor tissue can identify alterations that make certain drugs more effective. Treatment plans often integrate local and systemic approaches, coordinated to maximize control within the brain while managing disease elsewhere.
What to Expect During and After Treatment
Throughout care, you can expect regular follow-up with imaging and clinical assessment to monitor response and detect any changes early. Side effects are managed with supportive strategies, and rehabilitation services may be used to address cognition, mobility, or daily function. Long-term plans focus on surveillance, symptom control, and coordination with primary oncology and other providers involved in your overall care.
Coordination With Referring Providers
Duke Cancer Institute maintains structured communication with referring physicians, sharing treatment summaries, imaging findings, and molecular profiles. This collaboration ensures continuity of care, timely adjustments to therapy, and alignment on goals that reflect both cancer control and quality of life. Patients are encouraged to bring questions about their specific case, including how local and systemic treatments fit together over time.
Supportive and Rehabilitation Services
In addition to cancer-directed therapies, the institute incorporates supportive care services such as symptom management, nutrition, physical therapy, and psychological support. Rehabilitation may focus on walking, balance, speech, or cognitive strategies when needed, helping to maintain function and independence. Social work and survivorship resources also assist with practical and emotional challenges across the care journey.
Contact and Next Steps
To initiate a referral or learn more about evaluation at Duke Cancer Institute, contact your physician or the institute’s referral team. They can guide you on required records, imaging, and next steps for a timely and thorough assessment. Early coordination of care can help align treatment with your goals and ensure access to the latest, most appropriate options for brain metastases.